Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

glioblastoma multiforme

CNS Pharmaceuticals (CNSP.Q), the company that licenses the drug candidate Berubicin to WPD Pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation…